Although GLP-1RAs are known to have action in the brain, it is possible one mechanism by which GLP-1RAs reduce consumption of ingested drugs such as alcohol is, at least in part, through peripheral mechanisms
The BHF verdict We know that obesity increases your risk of many diseases, including having a heart attack or stroke
Diabetes and weight-loss trials have shown that the GLP-1 drugs target hormones in the gut and the brain that control appetite and feelings of fullness, cutting down on whats described as food noise, or intrusive thoughts of food
Long-Term Benefits (8+ Weeks) After about two months of consistent use, you can expect firmer, more lifted skin with a noticeable reduction in sagging and deeper wrinkles
No unexpected safety issues have arisen to date, and the established safety profile for semaglutide is similar to that of other GLP-1RAs where definitive conclusions for pancreatic and thyroid cancer cannot be drawn at this point due to low incidence of these conditions